Efficacy of educational sessions to modify the prescription of new drugs;Eficacia de las sesiones educativas para modificar la prescripción de fármacos nuevos

Atencion Primaria

Volumn 36, Issue 7, 2005, Pages 367-372

  Molina Lopez T ^a,f   Dominguez Camacho J C ^a   Santos Lozano, J M ^b   Carbonell Carrillo, A ^c   Sanchez Acevedo J ^d   Paz Leon M L ^e  

^a Especialidad Medicamento   (Spain)

^b Aragon Health Service   (Spain)

^c Centro de Salud Inmaculada Vieira Fuentes   (Spain)

^d Department of Family Medicine   (Spain)

^e Centro de Salud La Campana   (Spain)

^f Unidad de Farmacia   (Spain)

Author keywords

Drug prescriptions; Medical education; New drugs; Physician's practice patterns

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; EPROSARTAN;

ARTICLE; CONTROLLED STUDY; DRUG MARKETING; GENERAL PRACTITIONER; HEALTH CENTER; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; PRESCRIPTION;

EID: 28744436116     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080299     Document Type: Article

References (22)

1. Prescripción de nuevos medicamentos en atención primaria. Bol Ter Andal. 2001;17:17-20. Disponible en: www.easp.es/cadime
2. Lexchin J. Are new drugs as good as they claim to be? Aust Prescr. 2004;27:2-3.
3. Prosser H, Almond S, Walley T. Influences on GPs' decision to prescribe new drugs-the importance of who says what. Fam Pract. 2003;20:61-8.
4. McGettigan P, Golden J, Fryer J, Chan R, Feely J. Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol. 2001;51:184-9.
5. Jones MI, Greenfield SM, Bradley CP. Prescribing new drugs: qualitative study of influences on consultants and general practitioners. BMJ. 2001;323:378-81.
6. Peay MY, Peay ER. The role of comercial sources in the adoption of a new drug. Soc Sci Med. 1988;26:1183-9.
7. Ruiz de Velasco E, Unzueta L, Fernández J, Santisteban M, Lekue I. Prescripción inducida en atención primaria de la Comarca de Bilbao. Aten Primaria. 2002;29:414-20.
8. Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J. Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care. 2003;41:895-908.
9. Steffensen FH, Sorensen HT, Olesen F. Diffusion of new drugs in Danish general practice. Fam Pract. 1999;16:407-13.
10. Martin RM. When to use a new drug. Australian Prescriber. 1998;21:67-9.
11. Prescribing new drugs in general practice. Merec Bull. 1998;9:21-4.
12. Alastrué JL, Meneu R, Peiró S. Análisis de las opiniones, actitudes y conocimientos de los médicos de los centros de salud de Valencia sobre la eficacia y la eficiencia en la prescripción de medicamentos. Aten Primaria. 1998;21:165-71.
13. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J. 1995;153:1423-31.
14. University of York. NHS Centre for Reviews and Dissemination. Getting evidence into practice. Effective Health Care. 1999;5:16.
15. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Auditoría y devolución: efectos sobre la práctica profesional y los resultados de atención de la salud. En: Cochrane Library plus en español. Oxford: Update Software; enero 2005.
16. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Visitas educativas a distancia: efectos sobre los resultados de práctica profesional y de atención de la salud. En: Cochrane Library plus en español. Oxford: Update Software; enero 2005.
17. Thomson O'Brien MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Harvey EL. Local opinion leaders: effects on professional practice and health care outcomes (Cochrane Review). En: The Cochrane Library, Issue 4, 2003. Chichester: John Wiley & Sons, Ltd.; 2003.
18. Flottorp S, Oxman AD, Håvelsrud K, Treweek S, Herrin J. Cluster randomised controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat. BMJ. 2002;325:367-72.
19. Lundborg CS, Wahlstrom R, Tomson G, Diwan VK. Influencing prescribing for urinary tract infection and asthma in primary care in Sweden: a randomized controlled trial of an interactive intervention. J Clin Epidemiol. 1999;52:801-12.
20. Bernal-Delgado E, Galeote-Mayor M, Pradas-Arnal F, Peiro-Moreno S. Evidence based educational outreach visits: effects on prescriptions of non-steroidal anti-inflammatory drugs. J Epidemiol Community Health. 2002;56:653-8.
21. Van Eijk MEC, Avorn J, Porsius AJ, De Boer A. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ. 2001;322:1-6.
22. Flottorp S, Håvelsrud K, Oxman AD. Process evaluation of a cluster randomized trial of tailored interventions to implement guidelines in primary care: why is it so hard to change practice? Family Practice. 2003;20:333-9.